2063. Elucidating the Gram-Positive Selective Spectrum Activity of Ibezapolstat; Secondary Analysis from the phase 2a trial

BACKGROUND: Ibezapolstat (IBZ) is a non-absorbable antimicrobial currently in phase 2 clinical trials for the treatment of Clostridioides difficile infection (CDI). In vitro and human studies have shown potent activity of IBZ against C. difficile but selective activity against other beneficial Gram-...

Descripción completa

Detalles Bibliográficos
Autores principales: Lancaster, Chris, McPherson, Jacob, Alam, M Jahangir, Begum, Khurshida, Ekramul Karim, Md, Hu, Chenlin, Basseres, Eugenie, Garey, Kevin W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679124/
http://dx.doi.org/10.1093/ofid/ofad500.133

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679124/
http://dx.doi.org/10.1093/ofid/ofad500.133

Ejemplares similares